Decreasing use of controlled-release oxycodone: response to Morden et al, June 2008 Medical Care.
Katz
Mitchell H
MH
Kotabe
Sharon
S
D000701:Analgesics, Opioid / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D002140:California; D017046:Cost Savings; D003692:Delayed-Action Preparations; D016527:Drug Costs / Q000706:statistics & numerical data; D004363:Drug Utilization / Q000331:legislation & jurisprudence; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence*; D006801:Humans; D008484:Medicaid / Q000191:economics / Q000331:legislation & jurisprudence*; D010098:Oxycodone / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D010146:Pain / Q000188:drug therapy*; D019966:Substance-Related Disorders / Q000517:prevention & control*; D014481:United States
D000701:Analgesics, Opioid; D003692:Delayed-Action Preparations; D010098:Oxycodone